Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain

The trial results bring the biotech company one step closer to developing a drug that can provide strong pain relief without the addictive potential of opioids.

Previous post AMD shares fall as first-quarter forecast comes in light
Next post Starbucks’ results miss expectations. But one analyst says this is may be why the stock is up.